Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,599.00
Bid: 1,594.50
Ask: 1,595.50
Change: -19.00 (-1.17%)
Spread: 1.00 (0.063%)
Open: 1,608.00
High: 1,615.00
Low: 1,575.00
Prev. Close: 1,618.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: ITV drops as UK stocks retreat from 14-year high

Wed, 14th May 2014 11:50

- ITV leads fallers after underwhelming Q1- Markets pull back from highest level since 1999- BoE strikes dovish tone in Inflation Report- Compass, Mondi rise strongly after updatestechMARK 2,797.20 -0.25%FTSE 100 6,862.96 -0.15%FTSE 250 16,008.81 -0.19%UK stocks were in negative territory on Wednesday as the FTSE 100 retreated from a 14-year high the previous session, with ITV leading the decline after it underwhelmed with a trading update.London's benchmark index was down 0.15% at 6,863 by midday after hitting 6,873.08 on Tuesday, its best finish since reaching a record closing high of 6,930 at the end of December 1999. "Although upward progress has stalled for the moment, with 6,850 behind, it seems the index is finally about to break out of the trading range that has held it in check for the past few months," said Brenda Kelly, Chief Market Strategist at IG.Despite the slight pull-back this morning, losses were trimmed slightly after the Bank of England struck a dovish tone in its Inflation Report as it attempted to quell expectations for the first rate rise.Governor Mark Carney said the central bank is still in no rush to tighten policy with "significant slack remain[ing] in the labour market". He said while the economy has "edged closer" to the point at which the Bank Rate will need to gradually rise, the decision "will depend on the evolution of the economy, particularly the degree of slack, the prospects for its absorption, and the broader inflation outlook".Investors were also reacting to mixed economic data from the UK this morning. The Office for National Statistics reported that the UK unemployment rate fell from 6.9% to 6.8% in the three months to March, as expected by analysts; however, average weekly earnings growth remained subdued at just 1.7%, below forecasts.ITV slumps after underwhelming Q1Television network ITV fell sharply despite a seemingly in-line first-quarter statement with total external revenues up 2%. Analyst Steve Liechti from Investec said that the update "looks OK [with ad revenues] more or less as we expected", but "some bulls may have wanted more". The stock was down over 5% by midday.In contrast, catering giant Compass rose strongly as the company hiked its interim dividend after a solid first half and unveiled a £1bn capital return to investors. "Strong cash generation has underpinned our investment in the business and our commitment to reward shareholders," said Chief Executive Richard Cousins.Paper and packaging group Mondi was also higher after delivering a 13% increase in underlying operating profits in the first quarter despite a "mixed" trading environment and flat sales volumes.UK car insurer Admiral declined after reporting a 7% drop in first-quarter revenue as premiums continued to fall.On the second-tier FTSE 250, 3i Group, Partnership Assurance, Galliford Try, Wood Group and UDG Healthcare were all performing well after impressing with trading updates.Renishaw, however, declined after the engineering group said third-quarter profits were hit by currency movements.A number of heavyweight stocks were trading lower after going ex-dividend, including Aberdeen Asset Management, GlaxoSmithKline, Shell, Glencore Xstrata, Kingfisher and J Sainsbury.FTSE 100 - RisersMondi (MNDI) 1,064.00p +3.20%Compass Group (CPG) 1,011.00p +3.11%Aggreko (AGK) 1,710.00p +1.73%IMI (IMI) 1,591.00p +1.73%Experian (EXPN) 1,077.00p +1.13%Royal Mail (RMG) 572.00p +1.06%RSA Insurance Group (RSA) 487.80p +0.97%easyJet (EZJ) 1,674.00p +0.96%HSBC Holdings (HSBA) 616.40p +0.88%Old Mutual (OML) 209.90p +0.82%FTSE 100 - FallersITV (ITV) 180.80p -5.34%Sainsbury (J) (SBRY) 327.00p -3.54%Aberdeen Asset Management (ADN) 422.60p -2.96%Ashtead Group (AHT) 838.50p -2.39%Barratt Developments (BDEV) 377.70p -2.23%Kingfisher (KGF) 409.20p -1.99%Persimmon (PSN) 1,383.00p -1.50%Barclays (BARC) 251.55p -1.49%Glencore Xstrata (GLEN) 325.80p -1.47%BG Group (BG.) 1,253.00p -1.26%FTSE 250 - Risers3i Group (III) 397.30p +5.02%Imagination Technologies Group (IMG) 207.00p +4.39%Partnership Assurance Group (PA.) 129.00p +3.86%Wood Group (John) (WG.) 790.00p +2.66%Galliford Try (GFRD) 1,212.00p +2.45%St. Modwen Properties (SMP) 381.30p +2.23%Booker Group (BOK) 153.70p +2.19%JD Sports Fashion (JD.) 1,737.00p +2.00%UDG Healthcare Public Limited Company (UDG) 366.70p +1.86%African Barrick Gold (ABG) 233.90p +1.70%FTSE 250 - FallersRenishaw (RSW) 1,729.00p -5.98%Carillion (CLLN) 354.80p -3.38%Supergroup (SGP) 1,074.00p -3.24%COLT Group SA (COLT) 140.20p -2.84%Berkeley Group Holdings (The) (BKG) 2,332.00p -2.83%Alent (ALNT) 319.70p -2.80%Bank of Georgia Holdings (BGEO) 2,438.00p -2.48%Thomas Cook Group (TCG) 179.10p -2.24%Fidessa Group (FDSA) 2,297.00p -2.05%Bellway (BWY) 1,461.00p -1.95%BC
More News
20 Jun 2024 16:01

Industry groups back drugmakers' appeal in Zantac cancer lawsuits

June 20 (Reuters) - A bid by GSK and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued heartburn drug Zantac has received the backing of leading U.S. industry groups, including the United States Chamber of Commerce and Pharmaceutical Research and Manufacturers of America.

Read more
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.